# Sarah Stapleton

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sarah-stapleton/

## Facts

| Field | Value |
| --- | --- |
| Citations | 647 |
| Field | Ethics in Clinical Research |
| h-index | 6 |
| i10-index | 6 |
| Last Known Institution | Royal Marsden NHS Foundation Trust |
| OpenAlex ID | https://openalex.org/A5084138903 |
| ORCID iD | 0000-0002-1579-9447 |
| Works | 24 |

## Researcher papers

- [Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced Malignancies](https://scholariq.org/papers/phase-i-pharmacokinetic-and-pharmacodynamic-study-of-17-allylamino-17/)
- [A study of motivations and expectations of patients seen in phase 1 oncology clinics](https://scholariq.org/papers/a-study-of-motivations-and-expectations-of-patients-seen-in-phase-1-oncology/)
- [Insights into the experiences of patients with cancer in London: framework analysis of free-text data from the National Cancer Patient Experience Survey 2012/2013 from the two London Integrated Cancer Systems](https://scholariq.org/papers/insights-into-the-experiences-of-patients-with-cancer-in-london-framework/)
- [Identification of factors limiting patient recruitment into phase I trials: A study from the Royal Marsden Hospital](https://scholariq.org/papers/identification-of-factors-limiting-patient-recruitment-into-phase-i-trials-a/)
- [The lived experience of men with advanced cancer in relation to their perceptions of masculinity: a qualitative phenomenological study](https://scholariq.org/papers/the-lived-experience-of-men-with-advanced-cancer-in-relation-to-their/)
- [An extended mtDNA phylogeography for the alpine newt illuminates the provenance of introduced populations](https://scholariq.org/papers/an-extended-mtdna-phylogeography-for-the-alpine-newt-illuminates-the-provenance/)
- [Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT)](https://scholariq.org/papers/study-protocol-for-a-randomised-controlled-trial-of-enhanced-informed-consent/)
- [What is the impact of targeted therapies given within phase I trials on the cognitive function of patients with advanced cancer: a mixed-methods exploratory study conducted in an early clinical trials unit](https://scholariq.org/papers/what-is-the-impact-of-targeted-therapies-given-within-phase-i-trials-on-the/)
- [Unravelling the Impact of miR-21 Overexpression on the MicroRNA Network and Cancer Pathways](https://scholariq.org/papers/unravelling-the-impact-of-mir-21-overexpression-on-the-microrna-network-and/)
- [1886P Quantifying quality of informed consent (IC) in patients enrolled in phase I (ph I) oncology clinical trials with a validated instrument (QuIC Parts A, B) in a large United Kingdom phase I trials unit](https://scholariq.org/papers/1886p-quantifying-quality-of-informed-consent-ic-in-patients-enrolled-in-phase-i/)

## Researcher topics

- [Ethics in Clinical Research](https://scholariq.org/topics/ethics-in-clinical-research/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Biomedical Ethics and Regulation](https://scholariq.org/topics/biomedical-ethics-and-regulation/)
- [Cancer survivorship and care](https://scholariq.org/topics/cancer-survivorship-and-care/)
- [Patient-Provider Communication in Healthcare](https://scholariq.org/topics/patient-provider-communication-in-healthcare/)

## Researcher university

- [Royal Marsden NHS Foundation Trust](https://scholariq.org/institutions/royal-marsden-nhs-foundation-trust/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
